SYNTHAVERSE S.A.

Highlights Synthaverse S.A.

Equities

SVE

PLBMDLB00018

Market Closed - Warsaw S.E. Other stock markets 11:55:55 2024-05-31 EDT			5-day change	1st Jan Change
4.93 ^PLN	-1.30%		+0.20%	+15.46%

05-22	Synthaverse S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-10	Synthaverse S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Synthaverse S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-22	CI
Synthaverse S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	04-10	CI
Synthaverse S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-22	CI
Synthaverse S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-20	CI
BIOMED-LUBLIN WytwÃ³rnia Surowic i Szczepionek S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-26	CI
BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-20	CI
BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-07	CI
BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-07	CI
BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-26	CI
BIOMED-LUBLIN Wytw?rnia Surowic i Szczepionek S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-09	CI
BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-31	CI
Biomed-Lublin Wytwórnia Surowic I Szczepionek S.A. Announces Earnings Results for the First Quarter of 2021	21-05-28	CI
Biomed-Lublin Wytwórnia Surowic I Szczepionek S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-02	CI
BIOMED LUBLIN Announces Earnings Results for the First Half Year 2020	20-09-15	CI
Polpharma SA Pharmaceutical Works signed an agreement to acquire Production Rights to Lakcid, Lakcid Forte & Lakcid L Brands from BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek Spólka Akcyjna for PLN 17 million.	17-10-31	CI
Organizacja Polskich Dystrybutorow Farmaceutycznych S A acquired an additional 10.79% stake in BIOMED-LUBLIN Wytwornia Surowic i Szczepionek Spolka Akcyjna from Intra Stanislaw Bogdansk.	16-11-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer